ripekg:author/RIPEAUA4BE95C3CB80DAC4Xing-Yuan Shi |
rdf:type |
node1 |
ripekg:author/RIPEAUA4BE95C3CB80DAC4Xing-Yuan Shi |
rdf:type |
rdfs:Resource |
ripekg:author/RIPEAUA4BE95C3CB80DAC4Xing-Yuan Shi |
rdf:type |
owl:Thing |
ripekg:author/RIPEAUA4BE95C3CB80DAC4Xing-Yuan Shi |
rdf:type |
prov:Person |
ripekg:author/RIPEAUA4BE95C3CB80DAC4Xing-Yuan Shi |
rdf:type |
foaf:Person |
ripekg:author/RIPEAUA4BE95C3CB80DAC4Xing-Yuan Shi |
rdf:type |
ripe:AuthorAuthor |
ripekg:author/RIPEAUA4BE95C3CB80DAC4Xing-Yuan Shi |
owl:sameAs |
https://semopenalex.org/author/A5103011441 |
ripekg:author/RIPEAUA4BE95C3CB80DAC4Xing-Yuan Shi |
foaf:familyName |
Shi |
ripekg:author/RIPEAUA4BE95C3CB80DAC4Xing-Yuan Shi |
foaf:givenName |
Xing-Yuan |
ripekg:author/RIPEAUA4BE95C3CB80DAC4Xing-Yuan Shi |
foaf:name |
Xing-Yuan Shi |
ripekg:work/10.1136%2Fbmj-2024-081557Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trial |
dcterms:creator |
ripekg:author/RIPEAUA4BE95C3CB80DAC4Xing-Yuan Shi |